Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adolescent Medicine | 14 | 2020 | 73 | 1.880 |
Why?
|
Adolescent Health Services | 13 | 2015 | 220 | 1.390 |
Why?
|
Vaginal Smears | 10 | 2003 | 505 | 1.150 |
Why?
|
Contraceptives, Oral, Hormonal | 4 | 2014 | 190 | 0.870 |
Why?
|
Polycystic Ovary Syndrome | 8 | 2014 | 383 | 0.840 |
Why?
|
Sexual Behavior | 23 | 2018 | 2200 | 0.780 |
Why?
|
Mentors | 5 | 2018 | 672 | 0.760 |
Why?
|
Faculty, Medical | 8 | 2022 | 1225 | 0.700 |
Why?
|
Sexually Transmitted Diseases | 15 | 2015 | 668 | 0.650 |
Why?
|
Adolescent Behavior | 15 | 2003 | 1190 | 0.640 |
Why?
|
Child Abuse, Sexual | 11 | 1999 | 404 | 0.610 |
Why?
|
Counseling | 3 | 2014 | 1554 | 0.570 |
Why?
|
Contraceptives, Oral | 12 | 2000 | 560 | 0.560 |
Why?
|
Contraceptive Devices, Female | 2 | 2014 | 39 | 0.510 |
Why?
|
Academic Medical Centers | 6 | 2024 | 2784 | 0.490 |
Why?
|
Maternal-Child Health Centers | 1 | 2015 | 42 | 0.480 |
Why?
|
Education, Public Health Professional | 1 | 2015 | 27 | 0.480 |
Why?
|
Interdisciplinary Communication | 2 | 2011 | 937 | 0.470 |
Why?
|
Contraception Behavior | 4 | 2014 | 187 | 0.450 |
Why?
|
Transdermal Patch | 1 | 2014 | 51 | 0.450 |
Why?
|
Career Mobility | 3 | 2017 | 262 | 0.450 |
Why?
|
Adolescent | 115 | 2021 | 89247 | 0.450 |
Why?
|
Contraception | 3 | 2018 | 362 | 0.440 |
Why?
|
Leadership | 3 | 2021 | 1396 | 0.430 |
Why?
|
Sex Education | 6 | 2019 | 94 | 0.430 |
Why?
|
Physical Examination | 13 | 2007 | 1262 | 0.430 |
Why?
|
Menarche | 7 | 2010 | 538 | 0.420 |
Why?
|
Pregnancy in Adolescence | 10 | 2000 | 166 | 0.410 |
Why?
|
Pediatrics | 12 | 2024 | 3628 | 0.400 |
Why?
|
Health Knowledge, Attitudes, Practice | 12 | 2019 | 4053 | 0.400 |
Why?
|
Pelvic Inflammatory Disease | 6 | 2003 | 95 | 0.400 |
Why?
|
Menorrhagia | 2 | 2007 | 59 | 0.390 |
Why?
|
Professional Competence | 1 | 2015 | 430 | 0.380 |
Why?
|
Patient Compliance | 9 | 2003 | 2701 | 0.380 |
Why?
|
Uterine Cervical Dysplasia | 4 | 2003 | 392 | 0.350 |
Why?
|
Hymen | 4 | 1994 | 18 | 0.340 |
Why?
|
Risk-Taking | 9 | 2015 | 1025 | 0.340 |
Why?
|
Hyperandrogenism | 2 | 2008 | 46 | 0.340 |
Why?
|
Hepatitis B Vaccines | 2 | 2001 | 178 | 0.320 |
Why?
|
Staff Development | 2 | 2018 | 230 | 0.290 |
Why?
|
Contraceptive Agents, Female | 1 | 2008 | 123 | 0.280 |
Why?
|
Cystic Fibrosis | 3 | 2019 | 1295 | 0.280 |
Why?
|
Puberty | 7 | 2009 | 501 | 0.270 |
Why?
|
Amenorrhea | 6 | 1997 | 484 | 0.250 |
Why?
|
Sexual Partners | 5 | 2015 | 807 | 0.240 |
Why?
|
Female | 122 | 2020 | 397464 | 0.240 |
Why?
|
Preventive Medicine | 2 | 2003 | 246 | 0.230 |
Why?
|
Vulvovaginitis | 3 | 1993 | 14 | 0.220 |
Why?
|
Continuity of Patient Care | 2 | 2003 | 1076 | 0.220 |
Why?
|
Teaching | 3 | 2019 | 1171 | 0.220 |
Why?
|
Pelvis | 6 | 2000 | 738 | 0.220 |
Why?
|
Education, Medical | 3 | 2014 | 1742 | 0.210 |
Why?
|
Internship and Residency | 10 | 2018 | 5956 | 0.200 |
Why?
|
Curriculum | 7 | 2018 | 3782 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.200 |
Why?
|
Fellowships and Scholarships | 5 | 2017 | 1134 | 0.200 |
Why?
|
Condoms | 5 | 2001 | 338 | 0.200 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2003 | 2044 | 0.200 |
Why?
|
Levonorgestrel | 4 | 2003 | 80 | 0.190 |
Why?
|
Humans | 142 | 2024 | 768887 | 0.190 |
Why?
|
Anorexia Nervosa | 8 | 2002 | 1364 | 0.190 |
Why?
|
Confidentiality | 2 | 2008 | 606 | 0.190 |
Why?
|
Menstruation Disturbances | 5 | 1997 | 143 | 0.180 |
Why?
|
Hospitals, Pediatric | 4 | 2009 | 1876 | 0.180 |
Why?
|
Uterine Hemorrhage | 3 | 1999 | 237 | 0.180 |
Why?
|
Boston | 13 | 2017 | 9375 | 0.180 |
Why?
|
Hepatitis B Antibodies | 1 | 2001 | 156 | 0.180 |
Why?
|
Safe Sex | 1 | 2001 | 144 | 0.170 |
Why?
|
Ovary | 4 | 2014 | 965 | 0.170 |
Why?
|
Gonorrhea | 5 | 2003 | 355 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8745 | 0.170 |
Why?
|
Bacteriuria | 3 | 1991 | 102 | 0.170 |
Why?
|
Vulva | 2 | 1992 | 84 | 0.170 |
Why?
|
Needs Assessment | 3 | 2019 | 1142 | 0.160 |
Why?
|
Impulsive Behavior | 1 | 2002 | 349 | 0.160 |
Why?
|
Menstrual Cycle | 5 | 2010 | 546 | 0.160 |
Why?
|
Medroxyprogesterone Acetate | 3 | 2008 | 156 | 0.160 |
Why?
|
Interdisciplinary Studies | 2 | 2019 | 86 | 0.160 |
Why?
|
Patient Care Team | 1 | 2010 | 2527 | 0.150 |
Why?
|
Growth | 4 | 2001 | 366 | 0.150 |
Why?
|
Child | 47 | 2024 | 80969 | 0.150 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2002 | 360 | 0.150 |
Why?
|
Attitude to Health | 4 | 2001 | 2025 | 0.150 |
Why?
|
Physicians, Women | 3 | 2009 | 521 | 0.150 |
Why?
|
Tumor Virus Infections | 3 | 2003 | 437 | 0.150 |
Why?
|
Preventive Health Services | 2 | 2001 | 568 | 0.140 |
Why?
|
Thrombosis | 1 | 2011 | 2956 | 0.140 |
Why?
|
Women | 1 | 2018 | 225 | 0.140 |
Why?
|
Antimalarials | 1 | 2023 | 908 | 0.130 |
Why?
|
Sexual Maturation | 1 | 1998 | 261 | 0.130 |
Why?
|
Schools, Medical | 3 | 2022 | 882 | 0.130 |
Why?
|
Menstruation | 4 | 2009 | 310 | 0.130 |
Why?
|
Coitus | 2 | 1995 | 133 | 0.130 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3925 | 0.130 |
Why?
|
Precancerous Conditions | 2 | 2001 | 985 | 0.130 |
Why?
|
Chlamydia Infections | 3 | 2003 | 365 | 0.130 |
Why?
|
Anovulation | 2 | 1994 | 54 | 0.130 |
Why?
|
Communication Aids for Disabled | 1 | 1995 | 56 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 909 | 0.130 |
Why?
|
Genitalia, Female | 3 | 1992 | 146 | 0.120 |
Why?
|
United States | 22 | 2021 | 73180 | 0.120 |
Why?
|
Health Maintenance Organizations | 1 | 1998 | 657 | 0.120 |
Why?
|
Pelvic Pain | 1 | 1997 | 300 | 0.120 |
Why?
|
Gymnastics | 2 | 1993 | 27 | 0.120 |
Why?
|
Vaginitis | 4 | 2003 | 50 | 0.120 |
Why?
|
Health Behavior | 4 | 2001 | 2649 | 0.120 |
Why?
|
Menstrual Hygiene Products | 1 | 1994 | 20 | 0.120 |
Why?
|
Logistic Models | 6 | 2012 | 13317 | 0.120 |
Why?
|
Vitamin D Deficiency | 1 | 2004 | 1388 | 0.120 |
Why?
|
Progesterone Congeners | 2 | 2011 | 43 | 0.120 |
Why?
|
Research Support as Topic | 2 | 2009 | 696 | 0.110 |
Why?
|
Gardnerella vaginalis | 2 | 1991 | 20 | 0.110 |
Why?
|
Vagina | 3 | 1990 | 848 | 0.110 |
Why?
|
Hepatitis B | 1 | 1999 | 711 | 0.110 |
Why?
|
Goals | 3 | 2015 | 716 | 0.110 |
Why?
|
Hirsutism | 4 | 1996 | 68 | 0.110 |
Why?
|
Rape | 2 | 1998 | 131 | 0.110 |
Why?
|
Health Personnel | 3 | 2019 | 3382 | 0.110 |
Why?
|
Health Education | 1 | 2000 | 1059 | 0.110 |
Why?
|
Adult | 52 | 2018 | 223818 | 0.110 |
Why?
|
Mass Screening | 5 | 2002 | 5455 | 0.110 |
Why?
|
Endometriosis | 2 | 1997 | 874 | 0.110 |
Why?
|
Videotape Recording | 3 | 2001 | 336 | 0.100 |
Why?
|
Medical History Taking | 3 | 2019 | 779 | 0.100 |
Why?
|
Hospitalists | 1 | 2017 | 298 | 0.100 |
Why?
|
Outpatient Clinics, Hospital | 3 | 2003 | 395 | 0.100 |
Why?
|
Private Sector | 1 | 2015 | 396 | 0.100 |
Why?
|
Chlamydia trachomatis | 2 | 1991 | 239 | 0.100 |
Why?
|
Norethindrone | 1 | 1992 | 56 | 0.100 |
Why?
|
Women, Working | 1 | 2012 | 86 | 0.100 |
Why?
|
Fertility | 2 | 2018 | 770 | 0.100 |
Why?
|
Pyuria | 1 | 1991 | 30 | 0.090 |
Why?
|
Data Collection | 5 | 2001 | 3322 | 0.090 |
Why?
|
Women's Health | 1 | 2000 | 2081 | 0.090 |
Why?
|
Insurance Claim Review | 1 | 2015 | 746 | 0.090 |
Why?
|
Colposcopy | 3 | 1997 | 151 | 0.090 |
Why?
|
Program Evaluation | 2 | 2015 | 2507 | 0.090 |
Why?
|
Oligomenorrhea | 2 | 1980 | 42 | 0.090 |
Why?
|
Estrogens, Conjugated (USP) | 4 | 1997 | 277 | 0.090 |
Why?
|
Music | 3 | 1998 | 247 | 0.090 |
Why?
|
Vitamin D | 1 | 2004 | 3311 | 0.090 |
Why?
|
Bone Density | 4 | 2002 | 3573 | 0.090 |
Why?
|
Dehydroepiandrosterone | 2 | 2002 | 259 | 0.080 |
Why?
|
Vaginosis, Bacterial | 1 | 1991 | 154 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2015 | 26384 | 0.080 |
Why?
|
Estrogens | 2 | 1994 | 1537 | 0.080 |
Why?
|
Salaries and Fringe Benefits | 1 | 2011 | 262 | 0.080 |
Why?
|
Dexamethasone | 3 | 2000 | 1965 | 0.080 |
Why?
|
Program Development | 1 | 2015 | 1300 | 0.080 |
Why?
|
Violence | 5 | 1998 | 936 | 0.080 |
Why?
|
Neisseria gonorrhoeae | 1 | 1991 | 249 | 0.080 |
Why?
|
Papillomaviridae | 3 | 2003 | 1140 | 0.080 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2009 | 117 | 0.080 |
Why?
|
Age Factors | 8 | 2015 | 18454 | 0.070 |
Why?
|
Esterases | 1 | 1987 | 89 | 0.070 |
Why?
|
Clinical Enzyme Tests | 1 | 1987 | 114 | 0.070 |
Why?
|
Patient Access to Records | 1 | 2008 | 120 | 0.070 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2422 | 0.070 |
Why?
|
Hypothalamic Hormones | 1 | 2008 | 145 | 0.070 |
Why?
|
Massachusetts | 5 | 2015 | 8888 | 0.070 |
Why?
|
Prejudice | 2 | 2009 | 574 | 0.070 |
Why?
|
Vaccination | 1 | 1999 | 3436 | 0.070 |
Why?
|
Biomedical Research | 2 | 2024 | 3463 | 0.070 |
Why?
|
Axilla | 1 | 2009 | 625 | 0.070 |
Why?
|
Wilms Tumor | 1 | 2009 | 378 | 0.070 |
Why?
|
Research Personnel | 2 | 2009 | 590 | 0.070 |
Why?
|
Osteoporosis | 3 | 2008 | 1606 | 0.070 |
Why?
|
Sports Medicine | 1 | 1989 | 239 | 0.070 |
Why?
|
Male | 31 | 2020 | 365249 | 0.070 |
Why?
|
Hypogonadism | 2 | 1990 | 805 | 0.070 |
Why?
|
Adrenal Hyperplasia, Congenital | 2 | 1984 | 98 | 0.070 |
Why?
|
Young Adult | 7 | 2020 | 60110 | 0.060 |
Why?
|
Estrogen Replacement Therapy | 2 | 2002 | 1209 | 0.060 |
Why?
|
Progesterone | 1 | 2010 | 752 | 0.060 |
Why?
|
Trace Elements | 1 | 2007 | 193 | 0.060 |
Why?
|
Saliva | 1 | 2010 | 855 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2015 | 14795 | 0.060 |
Why?
|
Sex Factors | 7 | 2017 | 10641 | 0.060 |
Why?
|
Congresses as Topic | 1 | 2010 | 811 | 0.060 |
Why?
|
Health Care Surveys | 2 | 2003 | 2437 | 0.060 |
Why?
|
Television | 2 | 1998 | 410 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2181 | 0.060 |
Why?
|
Parents | 1 | 2018 | 3597 | 0.060 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2000 | 619 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2014 | 14751 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
Cosyntropin | 1 | 1983 | 34 | 0.060 |
Why?
|
Contraceptive Devices | 1 | 2003 | 25 | 0.060 |
Why?
|
Pregnancy | 13 | 2000 | 30175 | 0.060 |
Why?
|
Steroid Hydroxylases | 1 | 1983 | 93 | 0.060 |
Why?
|
Ethers | 1 | 2023 | 73 | 0.050 |
Why?
|
Psychosexual Development | 1 | 1983 | 19 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2007 | 2277 | 0.050 |
Why?
|
Predictive Value of Tests | 7 | 2003 | 15471 | 0.050 |
Why?
|
Health Expenditures | 1 | 2015 | 2396 | 0.050 |
Why?
|
Dyspareunia | 1 | 2003 | 48 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9682 | 0.050 |
Why?
|
Diagnosis, Differential | 4 | 2007 | 13020 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1196 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2003 | 147 | 0.050 |
Why?
|
Pharyngeal Diseases | 1 | 1983 | 134 | 0.050 |
Why?
|
Androstenes | 1 | 2003 | 186 | 0.050 |
Why?
|
Laparoscopy | 5 | 1999 | 2055 | 0.050 |
Why?
|
Genital Diseases, Female | 2 | 1980 | 192 | 0.050 |
Why?
|
Health Status | 1 | 2015 | 4095 | 0.050 |
Why?
|
Pulmonary Medicine | 1 | 2003 | 223 | 0.050 |
Why?
|
Papillomavirus Infections | 3 | 2003 | 1640 | 0.050 |
Why?
|
Exercise | 2 | 2002 | 5953 | 0.050 |
Why?
|
Statistics, Nonparametric | 3 | 2001 | 2862 | 0.050 |
Why?
|
Folic Acid Deficiency | 2 | 1996 | 117 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2024 | 373 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2000 | 705 | 0.040 |
Why?
|
Observer Variation | 2 | 2014 | 2623 | 0.040 |
Why?
|
Suburban Population | 2 | 1992 | 54 | 0.040 |
Why?
|
Immunization Schedule | 1 | 2001 | 228 | 0.040 |
Why?
|
Sexual Abstinence | 1 | 1999 | 17 | 0.040 |
Why?
|
Adnexal Diseases | 1 | 1980 | 105 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.040 |
Why?
|
Bottle Feeding | 1 | 1999 | 67 | 0.040 |
Why?
|
Clinical Competence | 2 | 2018 | 4859 | 0.040 |
Why?
|
Ego | 1 | 1999 | 98 | 0.040 |
Why?
|
Sports | 2 | 1984 | 703 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2280 | 0.040 |
Why?
|
Awards and Prizes | 2 | 2017 | 365 | 0.040 |
Why?
|
Career Choice | 3 | 2018 | 769 | 0.040 |
Why?
|
Pregnancy Tests | 1 | 1998 | 33 | 0.040 |
Why?
|
Contraceptives, Postcoital | 1 | 1998 | 15 | 0.040 |
Why?
|
Psychological Theory | 1 | 1999 | 174 | 0.040 |
Why?
|
Iron | 1 | 2007 | 1813 | 0.040 |
Why?
|
Pregnancy, Unwanted | 1 | 1998 | 24 | 0.040 |
Why?
|
Self-Assessment | 1 | 2001 | 400 | 0.040 |
Why?
|
Bone Resorption | 1 | 2002 | 728 | 0.040 |
Why?
|
Child Behavior | 2 | 2001 | 865 | 0.040 |
Why?
|
Seasons | 1 | 2004 | 1523 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2008 | 2059 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2009 | 39394 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6320 | 0.040 |
Why?
|
Appointments and Schedules | 2 | 1999 | 443 | 0.040 |
Why?
|
Socioeconomic Factors | 4 | 2017 | 7860 | 0.040 |
Why?
|
Weight Gain | 1 | 2008 | 2359 | 0.040 |
Why?
|
Anemia, Megaloblastic | 2 | 1996 | 24 | 0.040 |
Why?
|
Prospective Studies | 9 | 2010 | 54950 | 0.040 |
Why?
|
Glucose Intolerance | 1 | 2002 | 579 | 0.040 |
Why?
|
Plants, Toxic | 1 | 1997 | 70 | 0.040 |
Why?
|
Fallopian Tube Neoplasms | 1 | 1980 | 329 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2004 | 1803 | 0.040 |
Why?
|
Anemia | 1 | 2007 | 1516 | 0.040 |
Why?
|
Bulimia | 1 | 2000 | 405 | 0.040 |
Why?
|
Family Planning Services | 1 | 2000 | 279 | 0.040 |
Why?
|
Crime | 1 | 1998 | 206 | 0.040 |
Why?
|
Risk Factors | 7 | 2011 | 74971 | 0.040 |
Why?
|
World Health Organization | 1 | 2003 | 1327 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2000 | 557 | 0.030 |
Why?
|
Personnel Turnover | 1 | 2017 | 89 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 2000 | 1126 | 0.030 |
Why?
|
Algorithms | 2 | 2014 | 14199 | 0.030 |
Why?
|
Professional Autonomy | 1 | 2018 | 172 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2003 | 1398 | 0.030 |
Why?
|
Educational Status | 2 | 2002 | 2515 | 0.030 |
Why?
|
Nonprescription Drugs | 1 | 1997 | 119 | 0.030 |
Why?
|
Androgens | 4 | 1999 | 1285 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2003 | 1070 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2000 | 3438 | 0.030 |
Why?
|
Time Factors | 7 | 2017 | 40266 | 0.030 |
Why?
|
Vitamins | 1 | 2004 | 1638 | 0.030 |
Why?
|
Leuprolide | 1 | 1997 | 313 | 0.030 |
Why?
|
Social Class | 2 | 1999 | 2009 | 0.030 |
Why?
|
Migraine Disorders | 1 | 2008 | 1713 | 0.030 |
Why?
|
Prevalence | 4 | 2004 | 15875 | 0.030 |
Why?
|
Alcoholic Beverages | 1 | 1997 | 266 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1077 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2001 | 6242 | 0.030 |
Why?
|
17-Ketosteroids | 2 | 1988 | 36 | 0.030 |
Why?
|
Japan | 1 | 2000 | 1418 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 3110 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2000 | 829 | 0.030 |
Why?
|
Child, Preschool | 9 | 2009 | 42684 | 0.030 |
Why?
|
Osteogenesis | 1 | 2002 | 1295 | 0.030 |
Why?
|
Urban Population | 3 | 2001 | 2045 | 0.030 |
Why?
|
Vitamin B 12 Deficiency | 1 | 1996 | 119 | 0.030 |
Why?
|
Syphilis | 1 | 1998 | 243 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2008 | 1880 | 0.030 |
Why?
|
Anti-Bacterial Agents | 3 | 1993 | 7472 | 0.030 |
Why?
|
Cervix Uteri | 1 | 1999 | 576 | 0.030 |
Why?
|
Bone Remodeling | 1 | 1999 | 583 | 0.030 |
Why?
|
Specialty Boards | 1 | 2017 | 235 | 0.030 |
Why?
|
Focus Groups | 2 | 2018 | 1461 | 0.030 |
Why?
|
Conscious Sedation | 1 | 1999 | 534 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2000 | 866 | 0.030 |
Why?
|
Puberty, Precocious | 1 | 1996 | 166 | 0.030 |
Why?
|
Estradiol Congeners | 1 | 1994 | 22 | 0.030 |
Why?
|
Behavior | 1 | 1997 | 543 | 0.030 |
Why?
|
Reagent Strips | 2 | 1987 | 40 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2023 | 1469 | 0.030 |
Why?
|
Public Housing | 1 | 1995 | 140 | 0.030 |
Why?
|
Urination Disorders | 2 | 1987 | 238 | 0.030 |
Why?
|
Sex Counseling | 1 | 1993 | 18 | 0.030 |
Why?
|
Dietary Supplements | 2 | 2004 | 3442 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2018 | 645 | 0.030 |
Why?
|
Pain | 5 | 1999 | 5100 | 0.030 |
Why?
|
Aggression | 1 | 1998 | 750 | 0.030 |
Why?
|
Choice Behavior | 1 | 1999 | 848 | 0.030 |
Why?
|
Body Height | 2 | 1993 | 1568 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4300 | 0.030 |
Why?
|
Anabolic Agents | 1 | 1995 | 256 | 0.030 |
Why?
|
Video Recording | 1 | 1998 | 976 | 0.030 |
Why?
|
Probability | 1 | 1998 | 2483 | 0.030 |
Why?
|
Attitude | 1 | 1997 | 772 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2000 | 1842 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3345 | 0.020 |
Why?
|
Child Development | 2 | 2001 | 2337 | 0.020 |
Why?
|
Physician's Role | 2 | 1999 | 926 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2000 | 1728 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 1993 | 204 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2000 | 7460 | 0.020 |
Why?
|
Critical Pathways | 1 | 1995 | 476 | 0.020 |
Why?
|
Religion | 1 | 2015 | 376 | 0.020 |
Why?
|
Education, Medical, Undergraduate | 1 | 2000 | 1085 | 0.020 |
Why?
|
Regression Analysis | 3 | 2002 | 6346 | 0.020 |
Why?
|
Cannabis | 1 | 1997 | 446 | 0.020 |
Why?
|
Health Surveys | 1 | 2001 | 4055 | 0.020 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1991 | 99 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2007 | 15955 | 0.020 |
Why?
|
Homosexuality | 1 | 1991 | 269 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2003 | 3580 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2000 | 2167 | 0.020 |
Why?
|
Breast Feeding | 1 | 1999 | 1364 | 0.020 |
Why?
|
Osteocalcin | 2 | 2002 | 277 | 0.020 |
Why?
|
Specialization | 1 | 1995 | 780 | 0.020 |
Why?
|
Emergency Medical Services | 2 | 1999 | 1947 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2015 | 81892 | 0.020 |
Why?
|
Bone Development | 1 | 1993 | 473 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 1997 | 2709 | 0.020 |
Why?
|
Hospitals, University | 1 | 2011 | 570 | 0.020 |
Why?
|
Aftercare | 1 | 1995 | 921 | 0.020 |
Why?
|
Memory Disorders | 1 | 1996 | 1203 | 0.020 |
Why?
|
Gender Identity | 1 | 1995 | 770 | 0.020 |
Why?
|
Photography | 1 | 1992 | 537 | 0.020 |
Why?
|
Office Visits | 1 | 1993 | 596 | 0.020 |
Why?
|
Mothers | 1 | 1999 | 2211 | 0.020 |
Why?
|
Hypertension | 1 | 2008 | 8615 | 0.020 |
Why?
|
Recurrence | 1 | 2001 | 8512 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6213 | 0.020 |
Why?
|
Smoking | 4 | 1997 | 9094 | 0.020 |
Why?
|
Medical Records | 2 | 2008 | 1411 | 0.020 |
Why?
|
Achievement | 1 | 2009 | 288 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2946 | 0.020 |
Why?
|
Vulvitis | 1 | 1987 | 8 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2000 | 3206 | 0.020 |
Why?
|
Alkaline Phosphatase | 2 | 2002 | 864 | 0.020 |
Why?
|
Students | 1 | 1997 | 1744 | 0.020 |
Why?
|
Primary Health Care | 1 | 2004 | 4748 | 0.020 |
Why?
|
Infant | 4 | 2009 | 36541 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2001 | 3233 | 0.020 |
Why?
|
Communication | 1 | 2001 | 3908 | 0.020 |
Why?
|
Lymphogranuloma Venereum | 1 | 1987 | 14 | 0.020 |
Why?
|
Decision Making | 2 | 2018 | 3952 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 3143 | 0.020 |
Why?
|
Risk | 2 | 2015 | 9621 | 0.020 |
Why?
|
Trichomonas Vaginitis | 1 | 1987 | 33 | 0.020 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 1987 | 25 | 0.020 |
Why?
|
Haemophilus Infections | 1 | 1987 | 94 | 0.020 |
Why?
|
Academies and Institutes | 1 | 1989 | 326 | 0.020 |
Why?
|
Condylomata Acuminata | 1 | 1987 | 79 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 24330 | 0.020 |
Why?
|
Chronic Disease | 2 | 1998 | 9384 | 0.020 |
Why?
|
Medicine | 1 | 1995 | 947 | 0.020 |
Why?
|
Reference Values | 1 | 1994 | 4941 | 0.020 |
Why?
|
Computer Security | 1 | 2008 | 260 | 0.020 |
Why?
|
Scoliosis | 1 | 1993 | 793 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2002 | 3447 | 0.020 |
Why?
|
Diet | 1 | 2004 | 8090 | 0.020 |
Why?
|
Organizational Policy | 1 | 2008 | 434 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 1993 | 1145 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 13087 | 0.020 |
Why?
|
Herpes Genitalis | 1 | 1987 | 149 | 0.020 |
Why?
|
Interferons | 1 | 1989 | 720 | 0.020 |
Why?
|
Workload | 1 | 2011 | 852 | 0.020 |
Why?
|
Animals | 2 | 2023 | 169408 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 1989 | 411 | 0.020 |
Why?
|
Metronidazole | 1 | 1987 | 236 | 0.020 |
Why?
|
Pilot Projects | 4 | 2001 | 8742 | 0.020 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1984 | 36 | 0.010 |
Why?
|
Physical Exertion | 2 | 1984 | 668 | 0.010 |
Why?
|
Gonadal Dysgenesis | 1 | 1984 | 28 | 0.010 |
Why?
|
Urinary Tract Infections | 2 | 1982 | 805 | 0.010 |
Why?
|
Weight Loss | 1 | 1996 | 2720 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8765 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2126 | 0.010 |
Why?
|
Health Policy | 1 | 2017 | 2700 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1793 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 1990 | 1757 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1993 | 2203 | 0.010 |
Why?
|
Fluorouracil | 1 | 1989 | 1655 | 0.010 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1983 | 69 | 0.010 |
Why?
|
Public Health | 1 | 1997 | 2680 | 0.010 |
Why?
|
Students, Medical | 1 | 2017 | 1964 | 0.010 |
Why?
|
Hypothalamus | 1 | 1989 | 1004 | 0.010 |
Why?
|
Hydroxyprogesterones | 1 | 1983 | 24 | 0.010 |
Why?
|
Testosterone | 2 | 1988 | 2494 | 0.010 |
Why?
|
Substance-Related Disorders | 2 | 1998 | 4429 | 0.010 |
Why?
|
Energy Intake | 2 | 2002 | 2146 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1987 | 1609 | 0.010 |
Why?
|
Estradiol | 2 | 2002 | 1952 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1980 | 4919 | 0.010 |
Why?
|
Turner Syndrome | 1 | 1984 | 130 | 0.010 |
Why?
|
Follicular Phase | 1 | 1983 | 143 | 0.010 |
Why?
|
Dancing | 1 | 1984 | 105 | 0.010 |
Why?
|
Ovarian Diseases | 1 | 1984 | 137 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3814 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2359 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2002 | 1942 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1995 | 3726 | 0.010 |
Why?
|
Ethinyl Estradiol | 1 | 2002 | 114 | 0.010 |
Why?
|
Laser Therapy | 1 | 1989 | 1110 | 0.010 |
Why?
|
Prolactin | 1 | 1984 | 627 | 0.010 |
Why?
|
Disabled Persons | 1 | 1991 | 1210 | 0.010 |
Why?
|
Antifungal Agents | 1 | 1987 | 761 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 2000 | 4862 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2002 | 241 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2014 | 22294 | 0.010 |
Why?
|
American Medical Association | 1 | 2001 | 60 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20244 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 6001 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 1996 | 3743 | 0.010 |
Why?
|
Gonadotropins, Pituitary | 1 | 1980 | 70 | 0.010 |
Why?
|
Hospitalization | 2 | 2017 | 10845 | 0.010 |
Why?
|
Research | 1 | 2009 | 1981 | 0.010 |
Why?
|
Depression | 1 | 2000 | 8240 | 0.010 |
Why?
|
Uterus | 1 | 1984 | 661 | 0.010 |
Why?
|
Cohort Studies | 1 | 2003 | 41800 | 0.010 |
Why?
|
Sickle Cell Trait | 1 | 1980 | 86 | 0.010 |
Why?
|
Running | 1 | 1984 | 490 | 0.010 |
Why?
|
Adrenal Gland Diseases | 1 | 1980 | 141 | 0.010 |
Why?
|
Societies, Medical | 1 | 1991 | 3967 | 0.010 |
Why?
|
Teaching Materials | 1 | 1999 | 86 | 0.010 |
Why?
|
Patient Participation | 1 | 2008 | 1448 | 0.010 |
Why?
|
Collagen Type I | 1 | 2002 | 620 | 0.010 |
Why?
|
Heart Rate | 2 | 2001 | 4217 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5375 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 2002 | 1183 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1984 | 735 | 0.010 |
Why?
|
Firearms | 2 | 1997 | 632 | 0.010 |
Why?
|
Family Practice | 1 | 2001 | 509 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 1979 | 277 | 0.010 |
Why?
|
Endocrine System Diseases | 1 | 1980 | 250 | 0.010 |
Why?
|
HLA Antigens | 1 | 1983 | 1336 | 0.010 |
Why?
|
Vermont | 1 | 1998 | 80 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4265 | 0.010 |
Why?
|
Body Image | 1 | 2002 | 646 | 0.010 |
Why?
|
Laparotomy | 1 | 1979 | 459 | 0.010 |
Why?
|
Erotica | 1 | 1997 | 28 | 0.010 |
Why?
|
Asthma | 1 | 1996 | 6293 | 0.010 |
Why?
|
Prognosis | 2 | 2000 | 30044 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2001 | 1998 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1979 | 963 | 0.010 |
Why?
|
Acanthosis Nigricans | 1 | 1996 | 47 | 0.010 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 1996 | 62 | 0.010 |
Why?
|
Food | 1 | 2001 | 768 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1998 | 458 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1997 | 556 | 0.010 |
Why?
|
Age Distribution | 1 | 2001 | 2875 | 0.010 |
Why?
|
Posture | 1 | 1980 | 957 | 0.010 |
Why?
|
Adolescent, Hospitalized | 1 | 1995 | 30 | 0.010 |
Why?
|
Folic Acid | 1 | 1982 | 1336 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 1984 | 1326 | 0.010 |
Why?
|
Seat Belts | 1 | 1995 | 60 | 0.010 |
Why?
|
Suicide | 2 | 1998 | 1606 | 0.010 |
Why?
|
Gynecologic Surgical Procedures | 1 | 1998 | 289 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2001 | 941 | 0.010 |
Why?
|
Motorcycles | 1 | 1995 | 42 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1379 | 0.010 |
Why?
|
Forms and Records Control | 1 | 1995 | 158 | 0.010 |
Why?
|
Platelet Count | 1 | 1997 | 787 | 0.010 |
Why?
|
Referral and Consultation | 2 | 1999 | 3626 | 0.010 |
Why?
|
Head Protective Devices | 1 | 1995 | 118 | 0.010 |
Why?
|
Collagen | 1 | 2002 | 2646 | 0.010 |
Why?
|
Brain | 1 | 2001 | 27476 | 0.010 |
Why?
|
Adipose Tissue | 2 | 2002 | 3335 | 0.010 |
Why?
|
Gynecology | 1 | 1980 | 534 | 0.010 |
Why?
|
Abortion, Legal | 1 | 1995 | 121 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1979 | 1669 | 0.010 |
Why?
|
Crime Victims | 1 | 1998 | 347 | 0.010 |
Why?
|
Alcohol Drinking | 2 | 1997 | 4045 | 0.010 |
Why?
|
Functional Laterality | 1 | 2000 | 2269 | 0.010 |
Why?
|
Body Composition | 1 | 2002 | 2461 | 0.010 |
Why?
|
Nutrition Assessment | 1 | 1996 | 740 | 0.010 |
Why?
|
Random Allocation | 1 | 1997 | 2396 | 0.010 |
Why?
|
Abortion, Induced | 1 | 1998 | 471 | 0.010 |
Why?
|
Leptin | 1 | 2000 | 1597 | 0.010 |
Why?
|
Middle Aged | 3 | 2017 | 223740 | 0.010 |
Why?
|
Stress, Psychological | 2 | 1984 | 4542 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4628 | 0.010 |
Why?
|
HIV Infections | 1 | 1998 | 17589 | 0.010 |
Why?
|
Methods | 1 | 1991 | 1066 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2001 | 2736 | 0.010 |
Why?
|
Administration, Oral | 1 | 1999 | 4042 | 0.010 |
Why?
|
Acne Vulgaris | 1 | 1996 | 352 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 1629 | 0.010 |
Why?
|
Peptides | 1 | 2002 | 4353 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 1998 | 1438 | 0.010 |
Why?
|
Automobile Driving | 1 | 1995 | 442 | 0.010 |
Why?
|
Life Change Events | 1 | 1995 | 962 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3346 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1983 | 5544 | 0.010 |
Why?
|
Preoperative Care | 1 | 1998 | 2258 | 0.010 |
Why?
|
Leukemia | 1 | 1997 | 1520 | 0.010 |
Why?
|
Motivation | 1 | 1999 | 2030 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1989 | 26394 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12093 | 0.000 |
Why?
|
Interview, Psychological | 1 | 1991 | 810 | 0.000 |
Why?
|
Lymphoma | 1 | 1997 | 1900 | 0.000 |
Why?
|
Cytokines | 1 | 2002 | 7453 | 0.000 |
Why?
|
Clinical Protocols | 1 | 1993 | 1445 | 0.000 |
Why?
|
Length of Stay | 1 | 2000 | 6525 | 0.000 |
Why?
|
Medicaid | 1 | 1979 | 2843 | 0.000 |
Why?
|
Physician-Patient Relations | 1 | 1999 | 3269 | 0.000 |
Why?
|
Insulin | 1 | 2000 | 6610 | 0.000 |
Why?
|
Blood Glucose | 1 | 2000 | 6434 | 0.000 |
Why?
|
Cost of Illness | 1 | 1995 | 1959 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6031 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5834 | 0.000 |
Why?
|
Anxiety, Separation | 1 | 1984 | 86 | 0.000 |
Why?
|
Family | 1 | 1995 | 3208 | 0.000 |
Why?
|
Registries | 1 | 2000 | 8384 | 0.000 |
Why?
|
Premenstrual Syndrome | 1 | 1984 | 111 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2000 | 65485 | 0.000 |
Why?
|
Dysmenorrhea | 1 | 1984 | 107 | 0.000 |
Why?
|
Karyotyping | 1 | 1984 | 1177 | 0.000 |
Why?
|
Ferritins | 1 | 1982 | 600 | 0.000 |
Why?
|
Body Mass Index | 1 | 1996 | 13054 | 0.000 |
Why?
|